Raiees Andrabi, PhD

Results from a Scripps Research and UNC team pave the way for a vaccine and therapeutic antibodies that could be stockpiled to fight future coronavirus pandemics.

Finding opens the door for new vaccine approaches and strategies.

Certain antibodies isolated from people who had recovered from COVID-19 and were vaccinated have the ability to neutralize variety of coronaviruses.

Scientists identified vulnerable site on multiple coronaviruses that could be targeted to prevent future pandemics.

New understanding of how off-target antibodies hinder HIV vaccines’ success drives design improvements.

Scientists from Scripps Research investigated how the immune system’s previous exposure to cold-causing coronaviruses impact immune response to COVID-19. 

A protein from Simian Immunodeficiency Virus (SIV), which can infect monkeys and apes, has shown promise as a potential component of a vaccine against HIV. 

Cells removed from patients’ bloodstreams and genetically altered may allow more effective vaccines for HIV, influenza, hepatitis.